Schedule 13G ownership disclosure
DOVA PHARMACEUTICALS INC
Security class unavailable · CUSIP: 25985T102
Event date: 2019-11-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-19-293583
- Form type
- SC 13G
- Filer
- Dova Pharmaceuticals Inc.
- CIK
- CIK 1685071
- Filed
- Nov 18, 2019
- Reporting period
- Nov 12, 2019
- Description
- Schedule 13G beneficial ownership